Management of Influenza Virus Infections with Neuraminidase Inhibitors
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Treatments in Respiratory Medicine
- Vol. 4 (2), 107-116
- https://doi.org/10.2165/00151829-200504020-00004
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Molecular mechanisms of influenza virus resistance to neuraminidase inhibitorsVirus Research, 2004
- InfluenzaThe Lancet, 2003
- Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility NetworkJournal of Clinical Microbiology, 2003
- Logistic issues and potential prescribing costs associated with use of neuraminidase inhibitors for the treatment of influenza in primary careJournal of the Royal Society of Medicine, 2003
- Characterization of 2 Influenza A(H3N2) Clinical Isolates with Reduced Susceptibility to Neuraminidase Inhibitors Due to Mutations in the Hemagglutinin GeneThe Journal of Infectious Diseases, 2002
- In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675Journal of Virology, 2002
- ZanamivirDrugs, 2002
- Efficacy of Zanamivir against Avian Influenza A Viruses That Possess Genes Encoding H5N1 Internal Proteins and Are Pathogenic in MammalsAntimicrobial Agents and Chemotherapy, 2001
- OseltamivirDrugs, 2001
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999